Evidence map›Paper›PMID 37182900›Full record

ArticleJournal of Parkinson's disease2023

Predicting Motor Outcome and Quality of Life After Subthalamic Deep Brain Stimulation for Parkinson's Disease: The Role of Standard Screening Measures and Wearable-Data.

Victor J Geraedts, Jeroen P P van Vugt, Johan Marinus, Roy Kuiper, Huub A M Middelkoop, Rodi Zutt, Niels A van der Gaag, Carel F E Hoffmann, Lucille D A Dorresteijn, Jacobus J van Hilten and 1 more

Abstract read
In one paragraph

Article in Journal of Parkinson's disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Victor J GeraedtsDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Jeroen P P van VugtDepartment of Neurology, Medisch Spectrum Twente, Enschede, the Netherlands.
Johan MarinusDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Roy KuiperDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Huub A M MiddelkoopDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Rodi ZuttDepartment of Neurology, Haga Teaching Hospital, The Hague, the Netherlands.
Niels A van der GaagDepartment of Neurosurgery, Haga Teaching Hospital, The Hague, the Netherlands.
Carel F E HoffmannDepartment of Neurosurgery, Haga Teaching Hospital, The Hague, the Netherlands.
Lucille D A DorresteijnDepartment of Neurology, Medisch Spectrum Twente, Enschede, the Netherlands.
Jacobus J van HiltenDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Maria Fiorella ContarinoDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStandardized screening for subthalamic deep brain stimulation (STN DBS) in Parkinson's disease (PD) patients is crucial to determine eligibility, but its utility to predict postoperative outcomes in eligible patients is inconclusive. It is unknown whether wearable data can contribute to this aim.

objectiveTo evaluate the utility of universal components incorporated in the DBS screening, complemented by a wearable sensor, to predict motor outcomes and Quality of life (QoL) one year after STN DBS surgery.

methodsConsecutive patients were included in the OPTIMIST cohort study from two DBS centers. Standardized assessments included a preoperative Levodopa Challenge Test (LCT), and questionnaires on QoL and non-motor symptoms including cognition, psychiatric symptoms, impulsiveness, autonomic symptoms, and sleeping problems. Moreover, an ambulatory wearable sensor (Parkinson Kinetigraph (PKG)) was used. Postoperative assessments were similar and also included a Stimulation Challenge Test to determine DBS effects on motor function.

resultsEighty-three patients were included (median (interquartile range) age 63 (56-68) years, 36% female). Med-OFF (Stim-OFF) motor severity deteriorated indicating disease progression, but patients significantly improved in terms of Med-ON (Stim-ON) motor function, motor fluctuations, QoL, and most non-motor domains. Motor outcomes were not predicted by preoperative tests, including covariates of either LCT or PKG. Postoperative QoL was predicted by better preoperative QoL, lower age, and more preoperative impulsiveness scores in multivariate models.

conclusionData from the DBS screening including wearable data do not predict postoperative motor outcome at one year. Post-DBS QoL appears primarily driven by non-motor symptoms, rather than by motor improvement.

Indexed as

Deep Brain StimulationParkinson DiseaseSubthalamic NucleusWearable Electronic DevicesCohort StudiesFemaleHumansLevodopaMaleMiddle AgedQuality of LifeTreatment OutcomeLevodopaDeep brain stimulationmotor functionParkinson’s diseasequality of lifescreeningsubthalamic nucleus

Identifiers

PMID37182900
PMCPMC10357187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.